MORGANTOWN — Pfizer and two of its subsidiaries have agreed to a $345 million settlement in a four-year class-action antitrust lawsuit concerning Mylan's EpiPen. Pfizer subsidiary Meridian manufactures the EpiPen epinephrine auto-injector for Mylan. The plaintiffs alleged that Mylan and ...
MORGANTOWN – Mylan and its successor Viatris won a significant victory in a federal class-action antitrust suit alleging Mylan used its monopoly power to stifle competition and drive up the price of its EpiPen epinephrine auto-injector. The case was filed in 2017 in U.S. District Court ...
MORGANTOWN -- Viatris announced Friday that its predecessor Mylan has won a lawsuit filed by competitor Sanofi that alleged Mylan employed anticompetitive tactics to snuff out Sanofi’s failed EpiPen rival Auvi-Q. Sanofi sought up to $11.7 billion in damages in the suit. Sanofi filed the ...